The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.
Population-based genomic screening is at the forefront of a new approach to disease prevention.Yet the lack of diversity in genome wide association studies and ongoing debates about the appropriate use of racial and ethnic categories in genomics raise key questions about the translation of genomic knowledge into clinical practice.This article repor